Upper Extremity Rehabilitation With Virtual Reality in Parkinson's Disease Patients

Launched by RAMAZAN KURUL · Nov 22, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring how virtual reality (VR) can help improve the movement and function of the arms and hands in people with Parkinson's disease. Parkinson's often affects these upper body movements early on, and while VR has shown promise in helping with walking and balance, there hasn't been much research on its effects for arm rehabilitation. The study will look at whether specially designed VR exercises, which focus on matching arm positions, can help participants regain better control and function in their upper extremities.

To join the trial, participants need to have a diagnosis of Parkinson's disease from a neurologist and be able to walk independently. They should also be taking their Parkinson's medications as prescribed and have a specific level of movement ability in their shoulders and elbows. The study is open to all genders and is currently recruiting participants. Those who take part can expect to engage in VR exercises aimed at improving their arm movements, which could lead to better daily functioning. It's important for potential participants to know that certain medical conditions or cognitive issues may exclude them from the study, so it's best to discuss eligibility with a healthcare provider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Accepting to participate in the research
• • Being diagnosed with Parkinson's Disease by a neurologist
• • Continuing anti-parkinsonian medication
• • Hoehn-Yahr (H-Y) stage 3 and below
• • Ability to walk independently
• • To have full range of motion in shoulder abduction and elbow extension movements
• Exclusion Criteria:
• • Presence of additional neurological diseases other than Parkinson's Disease
• • Scores below 21 on the Montreal Cognitive Assessment Scale
• • Change in medication dosage in the last 1 month
• • Severe visual impairment or complete hearing impairment in both ears
• • Having a rheumatologic, musculoskeletal, etc. disease that may affect upper extremity functions
• • The occurrence of severe tremors or dyskinesias due to the end of the drug dose
• • Failing the Titmus butterfly test